Staun Michael, Pironi Loris, Bozzetti Federico, Baxter Janet, Forbes Alastair, Joly Francesca, Jeppesen Palle, Moreno Jose, Hébuterne Xavier, Pertkiewicz Marek, Mühlebach Stefan, Shenkin Alan, Van Gossum André
Department of Medical Gastroenterology, Rigshospitalet, Copenhagen, Denmark.
Clin Nutr. 2009 Aug;28(4):467-79. doi: 10.1016/j.clnu.2009.04.001. Epub 2009 May 22.
Home parenteral nutrition (HPN) was introduced as a treatment modality in the early 1970s primarily for the treatment of chronic intestinal failure in patients with benign disease. The relatively low morbidity and mortality associated with HPN has encouraged its widespread use in western countries. Thus there is huge clinical experience, but there are still few controlled clinical studies of treatment effects and management of complications. The purpose of these guidelines is to highlight areas of good practice and promote the use of standardized treatment protocols between centers. The guidelines may serve as a framework for development of policies and procedures.
家庭肠内营养(HPN)于20世纪70年代初作为一种治疗方式被引入,主要用于治疗良性疾病患者的慢性肠衰竭。HPN相对较低的发病率和死亡率促使其在西方国家广泛应用。因此,虽然有丰富的临床经验,但关于治疗效果和并发症管理的对照临床研究仍然很少。这些指南的目的是突出良好实践领域,并促进各中心之间使用标准化治疗方案。这些指南可作为制定政策和程序的框架。